Comparison of intra-articular injections of Hyaluronic Acid and Corticosteroid in the treatment of Osteoarthritis of the hip in comparison with intra-articular injections of Bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors

BMC Musculoskeletal Disorders

Volumn 11, Issue , 2010, Pages

  Colen, Sascha ^a   Van Den Bekerom, Michel P J ^b   Bellemans, Johan ^a   Mulier, Michiel ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; HYALURONIC ACID; METHYLPREDNISOLONE ACETATE; OSTENIL; UNCLASSIFIED DRUG; CORTICOSTEROID; LOCAL ANESTHETIC AGENT; VISCOSUPPLEMENT;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HARRIS HIP SCORE; HIP OSTEOARTHRITIS; HIP PAIN; HUMAN; MALE; PARALLEL DESIGN; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; TREATMENT OUTCOME; DISABILITY; DRUG COMBINATION; INTRAARTICULAR DRUG ADMINISTRATION; MIDDLE AGED; OUTCOME ASSESSMENT; PROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANESTHETICS, LOCAL; BUPIVACAINE; DISABILITY EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISCOSUPPLEMENTS;

EID: 78649910720     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-11-264     Document Type: Article

References (46)

1. COART France 2003 report on new socioeconomic data on osteoarthritis in France. C Reygrobellet C Le Pen, Presse Med 2004 33 4 6 10.1016/S0755-4982(04) 98700-3 15226681
2. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. RC Lawrence CG Helmick FC Arnett RA Deyo DT Felson EH Giannini, et al. Arthritis Rheum 1998 41 778 99 10.1002/1529- 0131(199805)41:5<778::AID-ART4>3.0.CO;2-V 9588729
3. Burden of major musculoskeletal conditions. AD Woolf B Pfleger, Bull World Health Organ 2003 81 646 56 14710506
4. Osteoarthrosis: Prevalence in the population and relationship between symptoms and x-ray changes. JS Lawrence JM Brenner F Bier, Ann Rheum Dis 1966 25 1 24 5905334
5. Incidence of symptomatic hand, hip and knee osteoarthritis among patients in health maintenance organizations. SA Oliveria DT Felson JI Reed PA Cirillo AM Walker, Arthritis Rheum 1995 38 1134 41 10.1002/art.1780380817 7639811
6. Idiopathic osteoarthritis of the hip and knee. A population-based incidence study. MG Wilson CJ Michet DM Ilstrup LJ Melton, Mayo Clin Proc 1990 65 1214 21 2402161
7. The efficacy of intra-articular steroids in osteoarthritis: a double blind study. DM Friedman ME Moore, J Rheumatol 1980 7 850 6 7009857
8. Radiographic patterns and response to corticosteroid hip injection. MJ Plant AA Borg K Dziedzic J Saklatvala PT Dawes, Ann Rheum Dis 1997 56 476 80 10.1136/ard.56.8.476 9306870
9. Radiographic follow-up of joints injected with triamcinolone hexacetonide for the management of childhood arthritis. M Sparling P Malleson B Wood R Petty, Arthritis Rheum 1990 33 821 6 10.1002/art.1780330608 2363737
10. Recommendations for the medical management of osteoarthritis of the hip and knee. RD Altman MC Hochberg RW Moskowitz TJ Schnitzer, Arthritis Rheum 2000 43 1905 1915 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P 11014340
11. Epidemiology of hip and knee osteoarthritis. DT Felson, Epidemiol Rev 1988 10 1 18 3066625
12. Intra-articular Sodium Hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. RD Altman R Moskowitz, et al. J Rheumatol 1998 25 11 2203 12 9818665
13. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis? T Concrozier E Vignon, Clin Exp Rheumatol 2005 23 711 716 16173254
14. What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systemic review of the literature. M Van den Bekerom B Lamme A Sermon M Mulier, Arch Orthop Trauma Surg 2008 128 815 23 10.1007/s00402-007-0447-z 17874246
15. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. E Qvistgaard R Christensen S Torp-Pedersen H Bliddal, Osteoarthritis and cartilage 2006 14 163 170 10.1016/j.joca.2005.09.007 16290043
16. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip arthritis: the OMERACT-OARSI criteria applied to the results of a pilot study. T Concrozier P Bertin F Bailleul P Mathieu J Charlot E Vignon R Treves X Chevalier, Joint Bone Spine 2006 73 705 9 10.1016/j.jbspin.2006.02.008 16997602
17. Efficacy and safety of intra-articular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. JC Fernndez Lopez A Ruano-Ravina, 2006 14 1306 11
18. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. WH Harris, J Bone Joint Surg Am 1969 51 737 55 5783851
19. Visual analogue scale for the assessment of total hip arthroplasty. F De Nies MW Fiddler, J Arthroplasty 1997 12 416 9 10.1016/S0883-5403(97)90197-2 9195317
20. Hip disability and osteoarthritis outcome score (HOOS) - validity and responsiveness in total hip replacement. AK Nilsdotter LS Lohmander M Klässbo EM Roos, BMC Musculoskelet Disord 2003 4 10 10.1186/1471-2474-4-10 12777182
21. Repeated ultrasound-guided intra-articular injections of 40 mg of Hyalgan may be useful in symptomatic relief of hip osteoarthritis. A Migliore S Tormenta U Massafra E Carloni C Padalino F Iannessi A Alimonti LS Martin M Granata, Osteoarthritis and cartilage 2005 13,1126 1127 10.1016/j.joca.2005.08. 001 16242357
22. Guidance by ultrasound of intra-articular injections in the knee and hip joints. E Qvistgaard H Kristoffersen L Terslev B Danneskiold-Samsoe S Torp-Pedersen H Bliddal, Osteoarthritis Cartilage 2001 9 512 7 10.1053/joca.2001.0433 11520164
23. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. A Migliore LS Martin A Alimonti C Valente S Tormenta, Osteoarthritis and cartilage 2003 11 305 306 10.1016/S1063-4584(03)00008-6 12681959
24. Proceedings of the United States Food and Drug Administration Advisory Panel on Orthopaedic and Rehabilitation Devices. R Fiorentini, Fairfax (VA): CASET Associates 1996
25. Inhibitory effects of different antioxidants on hyaluronan depolymerization. G Mendoza AI Alvarez MM Pulido AJ Molina G Merino R Real P Fernandes JG Prieto, Carbohydr Res 2007 342 1 96 102 10.1016/j.carres.2006.10. 027 17123492
26. Hylan versus Hyaluronic Acid for Osteoarthritis of the Knee: A Systematic Review and Meta-analysis. S Reichenbach S Blank AWS Rutjes A Shang E King P Dieppe P Jüni S Trelle, Arthritis Rheum 2007 57 1410 8 10.1002/art.23103 18050181
27. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis. Tikiz Canan Z Unlü A Sener M Efe C Tüzün, Clin Rheumatol 2005 24 244 250 10.1007/s10067-004-1013-5 15647968
28. Viscosupplementation in the hip: evaluation of hyaluronic acid formulations. MP Van den Bekerom B Rys M Mulier, Arch Orthop Trauma Surg 2008 128 275 80 10.1007/s00402-007-0374-z 17572901
29. Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients. MP Van den Bekerom G Mylle B Rys M Mulier, Acta Orthop Belg 2006 72 560 8 17152419
30. Bilateral symmetric inflammatory reaction to hylan G-F 20. PB Martens, Arthritis Rheum 2001 44 978 9 10.1002/1529-0131(200104)44:4<978::AID- ANR156>3.0.CO;2-N 11315938
31. Acute adverse reaction to hylan G-F 20: comment on the article by Martens [letter]. J Thomas Gil P Lopez Mateu J Alegre, Arthritis Rheum 2003 48 866
32. Successful nonoperative management of chronic osteoarthritis pin of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. M Pagnano G Westrich, Osteoarthritis Cartilage 2005 13 751 61 10.1016/j.joca.2005. 04.012 15967686
33. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. VM Goldberg RD Coutts, Clinica Orthop Relat Res 2004 419 130 7 10.1097/00003086-200402000-00021
34. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. P Robinson AM Keenan PG Conaghan, Rheumatology 2007 46 285 291 10.1093/rheumatology/kel217 16873380
35. Intra-articular corticosteroid injection: pain relief in osteoarthritis of the hip? B Kullenberg R Runesson R Tuvhag C Olsson S Resch, J Rheumatol 2004 31 2265 8 15517641
36. Steroid injection for osteoarthritis of the hip: A randomized, double-blind, placebo-controlled trial. RGW Lambert EJ Hutchings MGA Grace GS Jhangri B Connor-Spady WP Maksymowych, Arthritis Rheum 2007 56 2278 87 10.1002/art.22739 17599747
37. The role of the chondrocyte in osteoarthritis. MB Goldring, Arthritis Rheum 2000 43 1916 26 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0. CO;2-I 11014341
38. In vitro exposures to 0,5% bupivacaine is cytotoxic to bovine articular chondrocytes. CR Chu NJ Izzo NE Papas FH Fu, Arthroscopy 2006 22 693 9 10.1016/j.arthro.2006.05.006 16843803
39. Long-term effects of bupivacaine on cartilage in a rabbit shoulder model. AH Gomoll AB Yanke RW Kang S Chubinskaya JM Williams BR Bach BJ Cole, Am J Sports Med 2009 37 72 10.1177/0363546508323748 18832481
40. The effect of intra-articular instillation of bupivacaine on post-arthroscopic morbidity: a placebo-controlled, double-blind trial. TS Sorensen AI Sorensen K Strange, Arthroscopy 1991 7 364 367
41. Bupivacaine bolus injection versus placebo for pain management following total knee arthroplasty. C Browne S Copp L Reden P Pulido C Colwell, The Journal of Arthrosplasty 2004 19 377 80 10.1016/j.arth.2003.10.012 (Pubitemid 38519835)
42. Monitoring serum bupivacaine levels during arthroscopy. D Debruyne MA Moulin C Carmes JA Bequin B Locker, Eur J Clin Pharmacol 1985 27 733 5 10.1007/BF00547058 3987779
43. Bupivacaine use after knee arthroscopy pharmacokinetics and pain control study. CC Kaeding JA Hill J Katz L Benson, Arthroscopy 1990 6 ;33 9 10.1016/0749-8063(90)90094-T 2310448
44. The in vitro effects of bupivacaine on articular chondrocytes. CR Chu NJ Izzo CH Coyle NE Papas A Logar, J Bone Joint Surg Br 2008 90 814 20 10.2106/JBJS.G.01127 18539679
45. Missing Data in Clinical Studies. G Molenberghs MG Kenward, Hoboken NJ: John Wiley and Sons 2007
46. Outcome after femoral neck fractures: A comparison of Harris Hip Score, Eq-5 d and Barthel index. F Frihagen M Grotle JE Madsen TB Wyller P Mowickel L Nordsletten, Injury 2008 39 1147 56 10.1016/j.injury.2008.03.027 18656868